21 May 2009
Analysis of risk factors of postoperative haemodialysis treatment in kidney transplant recipients
M Zukowski, R Bohatyrewic, J Biernawska, K Katarzyna, M Zegan, M Ostrowski, I Sulikowski, K KedzierskaAnn Transplant 2009; 14(1): 48-48 :: ID: 880374
Abstract
Background: The quality of the transplanted kidney depends on many factors
that may debilitate its function, what can result in the necessity of haemodialysis treatment in the post operative period. Aims: Determining the influence of selected risk factors on the duration and number of haemodialysis post transplantation.
Material/Methods: Hemodynamic data was obtained from a group of 146
multi-organ donors. Group of 232 kidney transplant recipients was included in this study. Influence of the following factors on the duration and number of haemodialysis sessions in the postoperative period was analyzed: PRA value, HLA matching, length of haemodialysis prior to transplantation, donor's age and risk factors: MAP, CVP, PCWP, SVRI, dopamine infusion and CIT. Shapiro-Wilk, Kruskal-Wallis, Chi2 with the Yates correction and Fisher tests and analysis of correlation and regression were used, p=0.05.
Results: Decreased duration and fewer dialysis sessions were observed in the recipients, who had their kidney transplanted from the donors with MAP >70 mmHg, PCWP >12 mmHg and dopamine infusion <10 μg/kg/min. Positive correlation was observed between BSA, dopamine dose infusion, recipient's
age, length of haemodialysis prior to transplantation and the duration of the haemodialysis required post transplant.
Conclusions: 1) Increased MAP and PCWP in the donor both have a major influence on decreasing the duration of haemodialysis of kidney recipient post transplantation; 2) Increased BSA, dopamine dose infusion requirements in the donor, age and duration of haemodialysis before transplantation substantially prolong the duration of haemodialysis post transplantation.
Keywords: Kidney Transplantation, Organ Procurement
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






